GARLIC PHYTOCHEMICALS POSSIBLE BENEFIT IN HORMONE-RELATED CANCERS
This article was originally published in The Tan Sheet
Executive Summary
GARLIC PHYTOCHEMICALS POSSIBLE BENEFIT IN HORMONE-RELATED CANCERS suggested in several presentations of preliminary findings of studies discussed at the Designer Foods III conference in Washington, D.C. May 23-25. Researcher John Pinto, PhD, Memorial Sloan-Kettering Cancer Center, asserted that "at several sites ...you see that a number of some of the phytochemicals that exist in food can prevent the [cancer] initiation phase. Many of the compounds in foods certainly act as antioxidants and can block the promotion of tumors and certainly can inhibit a number of hormones that impinge on the growth of hormone-sensitive tissues, particularly breast and prostate."